Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

CLINICAL TRIALS AND PRECLINICAL INFRASTRUCTURE ASSET MAP
83
The Vancouver Prostate Centre
The Vancouver Prostate Centre (www.prostatecentre.com) (www.pctriadd.com) is a world-class research,
translational, and clinical facility that works on all aspects of prostate disease including cancer,
bladder problems, and kidney disease. The Clinical Trials Unit resides within this Centre.
The Clinic conducts Phases I, II, III, and IV clinical trials, as well as investigator-initiated, National Cancer
Institute of Canada (NCIC), Canadian Urologic Oncology Group (CUOG), and Canadian Urology Research
Consortium (CURC) studies. The Clinic sees approximately 1,000 new patients/year. It is able to
enroll 800 – 1,200 patients in clinical trials, depending on eligibility (10-15% of the approximately 8,000
patients registered with the Clinic).
The facility has 13 investigators, whose details can be found in Appendix 6:
• Black, Peter • Kollmannsberger, Christian
• Chew, Ben • Nguan, Chris
• Chi, Kim • Nigro, Mark
• Davison, Joyce • Patterson, Ryan
• Fenster, Howard • So, Alan
• Gleave, Martin E. • Stothers, Lynn
• Goldenberg, Larry
Staffing of the unit is as follows:
Study Nurses/
Coordinators 1
Research Assistants
3
Data Managers/
Coordinators
Pharmacy/ Lab
Staff
Admin IT
4* 1.5* 0 0 1** 1
* There are 2 coordinators and 2 nurses. Also involved in data collection and data entry, i.e., perform Data Manager/Coordinator role.
** Part-time unit manager who is also one of the study nurses.
The unit uses laboratory and pharmacy staff outside Vancouver General Hospital in its conduct of clinical
trials.
Quality control/assurance procedures are based on extensive Standard Operating Procedures which
are read and signed by all staff and updated as required (minimum annually). Furthermore, all investigators/staff
have completed the “NCI Human Participant Protections Education for Research Teams online
course”, have read the “GCP Guidelines”, and have a Certificate of Completion of the “NCIC CTG Certificate
on GCP Guidelines”. All projects are approved by the REB prior to initiation.
Contact:
Palmer, Maureen. R.N. Tel: 604-875-5675. maureen.palmer@vch.ca.
Vancouver Retinal Research Group
Based at the VGH/ UBC Eye Care Centre, the Vancouver Retinal Research Group conducts Phases II and
III clinical trials, as well as investigator initiated and grant funded studies into macular degeneration,
diabetic retinopathy, and central retina vein occlusion. It offers study design, protocol preparation,
budget preparation, ethics applications, source documents, and study facilitation (i.e., coordinates study
procedure with various departments and investigators, study staff training, and oversight). It has no
independent URL.